Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites

Brain Research

Volumn 1129, Issue 1, 2007, Pages 191-199

  Hashemi, Ezzat ^a   Sahbaie, Peyman ^a   Davies, M Frances ^b   Clark, J David ^b,c   DeLorey, Timothy M ^a  

^a MOLECULAR RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Gabrb3 gene; Hypotonia; Locus coeruleus; Risk assessment

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DENDRITE; FEMALE; GABRB3 GENE; GENE; LOCUS CERULEUS; MALE; MAZE TEST; MOUSE; MUSCLE HYPOTONIA; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; DENDRITES; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LOCUS COERULEUS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE HYPOTONIA; NERVOUS SYSTEM MALFORMATIONS; NEURAL INHIBITION; RECEPTORS, GABA-A; RISK-TAKING; SYNAPTIC TRANSMISSION;

MUS;

EID: 33845995380     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.10.050     Document Type: Article

References (71)

1. Abe M., et al. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice. Jpn. J. Pharmacol. 76 (1998) 297-304
2. Andre P., et al. Microinjections of GABAergic agents in the locus coeruleus modify the gain of vestibulospinal reflexes in decerebrate cats. Arch. Ital. Biol. 133 (1995) 47-75
3. Aston-Jones G., and Cohen J.D. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28 (2005) 403-450
4. Aston-Jones G., et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 88 (1991) 47-75
5. Aston-Jones G., et al. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J. Neurosci. 24 (2004) 2313-2321
6. Bailey A., et al. A clinicopathological study of autism. Brain 121 Pt. 5 (1998) 889-905
7. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42 (2003) 33-84
8. Blanchard D.C., et al. The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic. Eur. J. Pharmacol. 463 (2003) 97-116
9. Bonnert T.P., et al. theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9891-9896
10. Bourin M. Animal models of anxiety: are they suitable for predicting drug action in humans?. Pol. J. Pharmacol. 49 (1997) 79-84
11. Bremner J.D., et al. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23 (1996) 28-38
12. Brunner D., et al. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav. Neurosci. 113 (1999) 587-601
13. Buxbaum J.D., et al. Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7 (2002) 311-316
14. Charney D.S., et al. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry 41 (1984) 751-763
15. Cook Jr. E.H., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 62 (1998) 1077-1083
16. Davies M.F., et al. Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory. Brain Res. 986 (2003) 157-165
17. DeLorey T.M. Gabrb3 gene deficient mice: a potential model of autism spectrum disorder. In: Dhossche D.M. (Ed). International Review of Neurobiology vol. 71 (2005), Elsevier Science Publishing Co. Inc., New York 359-382
18. DeLorey T.M., et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18 (1998) 8505-8514
19. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav. Brain Res. 125 (2001) 151-157
20. Freitag S., et al. Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav. Brain Res. 145 (2003) 189-207
21. Goddard A.W., and Charney D.S. Toward an integrated neurobiology of panic disorder. J. Clin. Psychiatry 58 Suppl. 2 (1997) 4-11 (discussion 11-2)
22. Griebel G., et al. Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study. Physiol. Behav. 60 (1996) 1255-1260
23. Gyertyan I. Analysis of the marble burying response: marbles serve to measure digging rather than evoke burying. Behav. Pharmacol. 6 (1995) 24-31
24. Homanics G.E., et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4143-4148
25. Ichimaru Y., et al. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn. J. Pharmacol. 68 (1995) 65-70
26. Iijima K. Chemocytoarchitecture of the rat locus ceruleus. Histol. Histopathol. 8 (1993) 581-591
27. Ikegami S., et al. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci. Lett. 279 (2000) 129-132
28. Insel T.R. Mouse models for autism: report from a meeting. Mamm. Genome 12 (2001) 755-757
29. Jiang M., et al. Activation of locus coeruleus enhances the responses of olfactory bulb mitral cells to weak olfactory nerve input. J. Neurosci. 16 (1996) 6319-6329
30. Johansson A.K., and Hansen S. Increased novelty seeking and decreased harm avoidance in rats showing Type 2-like behaviour following basal forebrain neuronal loss. Alcohol Alcohol. 36 (2001) 520-524
31. Jones S.L., and Gebhart G.F. Quantitative characterization of ceruleospinal inhibition of nociceptive transmission in the rat. J. Neurophysiol. 56 (1986) 1397-1410
32. Kemper T.L., and Bauman M.L. The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11 (1993) 175-187
33. Kiyashchenko L.I., et al. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J. Neurophysiol. 85 (2001) 2008-2016
34. Konig N., et al. Tyrosine hydroxylase and serotonin containing cells in embryonic rat rhombencephalon: a whole-mount immunocytochemical study. J. Neurosci. Res. 20 (1988) 212-223
35. Lahdesmaki J., et al. Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice. Neuroscience 113 (2002) 289-299
36. Lauder J.M., et al. Prenatal ontogeny of the GABAergic system in the rat brain: an immunocytochemical study. Neuroscience 19 (1986) 465-493
37. Luque J.M., et al. Localization of GABAA receptor subunit mRNAs in the rat locus coeruleus. Brain Res. Mol. Brain Res. 24 (1994) 219-226
38. Martchek M., et al. Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathol. 111 (2006) 497-499 (Berl.)
39. Masuda Y., et al. Digging behavior of ddY mouse. Exp. Anim. 49 (2000) 235-237
40. Mokha S.S., et al. Descending control of spinal nociceptive transmission. Actions produced on spinal multireceptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM). Exp. Brain Res. 58 (1985) 213-226
41. Njung'e K., and Handley S.L. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br. J. Pharmacol. 104 (1991) 105-112
42. Njung'e K., and Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 38 (1991) 63-67
43. Nusser Z., et al. Disruption of GABA(A) receptors on GABAergic interneurons leads to increased oscillatory power in the olfactory bulb network. J. Neurophysiol. 86 (2001) 2823-2833
44. Ogura H., et al. Behavioral abnormalities of Zic1 and Zic2 mutant mice: implications as models for human neurological disorders. Behav. Genet. 31 (2001) 317-324
45. Olsen R.W., and DeLorey T.M. GABA and glycine. In: Siegel G.J., Agranoff B.W., Albers R.W., and Molinoff P.B. (Eds). Basic Neurochemistry. 6th edition (1999), Raven press, New York 335-346
46. Osmanovic S.S., and Shefner S.A. Enhancement of current induced by superfusion of GABA in locus coeruleus neurons by pentobarbital, but not ethanol. Brain Res. 517 (1990) 324-329
47. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego, CA
48. Pompeiano O. Role of the locus coeruleus in the static and dynamic control of posture. Arch. Ital. Biol. 139 (2001) 109-124
49. Prater C.D., and Zylstra R.G. Autism: a medical primer. Am. Fam. Physician 66 (2002) 1667-1674
50. Priolo E., et al. Panic-like attack induced by microinfusion into the locus coeruleus of antagonists and inverse agonists at GABAA-receptors in rodents. Funct. Neurology 6 (1991) 393-403
51. Pudovkina O.L., et al. The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. Eur. J. Pharmacol. 445 (2002) 37-42
52. Ramboz S., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14476-14481
53. Rasmussen K., and Jacobs B.L. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res. 371 (1986) 335-344
54. Ribeiro-Barbosa E.R., et al. An alternative experimental procedure for studying predator-related defensive responses. Neurosci. Biobehav. Rev. 29 (2005) 1255-1263
55. Rodgers R.J., and Cole J.C. Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol. Behav. 54 (1993) 729-736
56. Roy V., and Chapillon P. Further evidences that risk assessment and object exploration behaviours are useful to evaluate emotional reactivity in rodents. Behav. Brain Res. 154 (2004) 439-448
57. Salchner P., et al. Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 50 (2006) 1048-1058
58. Sanna E., et al. Enhancement of GABA-dependent chloride channel by "in vivo" administration of ethanol. Pharmacol. Res. 22 Suppl. 1 (1990) 91-92
59. Scotti de Carolis A., et al. Neuropharmacological investigations on muscimol, a psychotropic drug extracted from Amanita muscaria. Psychopharmacologia 15 (1969) 186-195
60. Segawa M. A neurologic model of early infantile autism. No To Hattatsu 21 (1989) 170-180
61. Shao Y., et al. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am. J. Hum. Genet. 72 (2003) 539-548
62. Shipley M.T., et al. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 365 (1996) 56-68
63. Siegel J.M., et al. Activity of medial mesopontine units during cataplexy and sleep-waking states in the narcoleptic dog. J. Neurosci. 12 (1992) 1640-1646
64. Skalisz L.L., et al. Effect of Hypericum perforatum on marble-burying by mice. Phytother. Res. 18 (2004) 399-402
65. Tanaka M., et al. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur. J. Pharmacol. 405 (2000) 397-406
66. Tsai T.F., et al. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome. Hum. Mol. Genet. 8 (1999) 1357-1364
67. Ugarte S.D., et al. Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the beta3 subunit of the GABA(A) receptor. Neuroscience 95 (2000) 795-806
68. Wisor J.P., et al. Sleep states and sleep electroencephalographic spectral power in mice lacking the beta 3 subunit of the GABA(A) receptor. Brain Res. 955 (2002) 221-228
69. Wolpert C.M., et al. Three probands with autistic disorder and isodicentric chromosome 15. Am. J. Med. Genet. 96 (2000) 365-372
70. Woods-Kettelberger A., et al. Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder. Expert Opin. Invest. Drugs 6 (1997) 1369-1381
71. Yamada K., et al. Decreased marble burying behavior in female mice lacking neuromedin-B receptor (NMB-R) implies the involvement of NMB/NMB-R in 5-HT neuron function. Brain Res. 942 (2002) 71-78